Market Overview

Calls Purchased on Savient Pharmaceuticals


Shares of Savient Pharmaceuticals (NASDAQ: SVNT) are lower on the session by 3.25%, currently trading at $4.46. The stock has been moving largely lower over the past three months and is currently trading below the 50-day moving average.

Options traders are buying calls on the name today. A short while ago the December 2011 $5.00 call traded 3,000 times on open interest of 10 contracts. Overall call volume is now running at 8.27x the daily average with 94% of all calls traded being purchases on the offer.

Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on commercializing KRYSTEXXA in the United States and completing the development and seeking regulatory approval outside of the United States for KRYSTEXXA, particularly in the European Union.

Posted-In: Options


Related Articles (SVNT)

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial
Book A Demo
Learn How You Can Succeed In The Market With Benzinga Pro

Fastest Market News

Real-Time News Alerts

Customizable News Filters

Book A Demo

6 Tech Stocks to Buy for Big Profits in 2012

Calls Purchased on R.R. Donnelley & Sons